Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

681 ARTÍCULOS , VIENDO DEL 91 AL 105

Optogenetics: implications for Alzheimer's disease research and therapy

Mirzayi P, Shobeiri P, Kalantari A, Perry G, Rezaei N.

Mol Brain. 2022 Feb 23;15(1):20. doi: 10.1186/s13041-022-00905-y.

Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment

Rajeev V, Fann DY, Dinh QN, Kim HA, De Silva TM, Lai MKP, Chen CL, Drummond GR, Sobey CG, Arumugam TV.

Theranostics. 2022 Jan 16;12(4):1639-1658. doi: 10.7150/thno.68304. eCollection 2022.

Examining a role for the retrosplenial cortex in age-related memory impairment

Trask S, Fournier DI.

Neurobiol Learn Mem. 2022 Mar;189:107601. doi: 10.1016/j.nlm.2022.107601. Epub 2022 Feb 22.

Novel Nutraceutical Compounds in Alzheimer Prevention

Maccioni RB, Calfío C, González A, Lüttges V.

Biomolecules. 2022 Feb 3;12(2):249. doi: 10.3390/biom12020249.

Phenolic Acids and Prevention of Cognitive Decline: Polyphenols with a Neuroprotective Role in Cognitive Disorders and Alzheimer's Disease

Caruso G, Godos J, Privitera A, Lanza G, Castellano S, Chillemi A, Bruni O, Ferri R, Caraci F, Grosso G.

Nutrients. 2022 Feb 15;14(4):819. doi: 10.3390/nu14040819.

Aducanumab and Its Effects on Tau Pathology: Is This the Turning Point of Amyloid Hypothesis?

Silvestro S, Valeri A, Mazzon E.

Int J Mol Sci. 2022 Feb 11;23(4):2011. doi: 10.3390/ijms23042011.

Anthocyanin as a therapeutic in Alzheimer's disease: A systematic review of preclinical evidences

Suresh S, Begum RF, Singh S A, V C.

Ageing Res Rev. 2022 Apr;76:101595. doi: 10.1016/j.arr.2022.101595. Epub 2022 Feb 23.

Electroconvulsive Therapy Reverses Cerebral Hypoperfusion in a Patient With Psychotic Depression and Catatonia

Howells D, Rees J, Townsend R, Kirov G.

J ECT. 2022 Jun 1;38(2):141-143. doi: 10.1097/YCT.0000000000000836. Epub 2022 Feb 25.

A likely case of progression from mild cognitive impairment to dementia in Yasunari Kawabata's The Sound of the Mountain

Pedro MKF, Machado AB.

Arq Neuropsiquiatr. 2022 Mar;80(3):330-332. doi: 10.1590/0004-282X-ANP-2021-0373.

"Exceptions that prove the rule"-Why have clinical trials failed to show efficacy of risk factor interventions suggested by observational studies of the dementia-Alzheimer's disease syndrome?

Breitner JCS, Dodge HH, Khachaturian ZS, Khachaturian AS.

Alzheimers Dement. 2022 Mar;18(3):389-392. doi: 10.1002/alz.12633. Epub 2022 Mar 4.

Case report: Late-onset mania as a presentation of underlying Lewy body disease

Kasanuki K, Nishiguchi M, Hagiwara M, Natsume S, Katsuta N, Ichimiya Y, Sato K.

Bipolar Disord. 2022 Sep;24(6):693-696. doi: 10.1111/bdi.13200. Epub 2022 Mar 10.

Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer's disease

Bairamian D, Sha S, Rolhion N, Sokol H, Dorothée G, Lemere CA, Krantic S.

Mol Neurodegener. 2022 Mar 5;17(1):19. doi: 10.1186/s13024-022-00522-2.

Sixteen Weeks of Aerobic Exercise does not Alter Resting-state Connectivity of the Precuneus in Patients with Alzheimer's Disease

Musaeus CS, Johansen LB, Hasselbalch S, Beyer N, Høgh P, Siebner HR, Frederiksen KS.

Curr Alzheimer Res. 2022;19(2):171-177. doi: 10.2174/1567205019666220304091241.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias